Brain Mapping Instruments Market To Reach $2.90 Billion By 2030

Brain Mapping Instruments Market Growth & Trends

The global brain mapping instruments market size is anticipated to reach USD 2.90 billion by 2030, according to a new report by Grand View Research, Inc. expanding at a CAGR of 5.8% from 2024 to 2030, increasing incidence of brain ailments as well as other neurological diseases and rising adoption of advanced technology and increasing awareness of neurodiagnostic imaging is anticipated to boost the market’s growth.

Increase in the number of patients suffering from neurological diseases such as Alzheimer’s disease, epilepsy, and Traumatic Brain Injury (TBI) are anticipated to propel this market’s growth. It also includes patients who suffer from physical injuries to the brain such as concussion. According to the American Society of Neuroradiology (ASNR), more than 75% of TBI are termed as concussion due to their mild nature of occurrence. According to the University of Pittsburgh's Brain Trauma Research Center, more than 3,00,000 concussions occurring in the U.S. annually, are mainly sports related.

Technological advancement includes 3D brain images using magnetic resonance imaging (MRI). Medtronic started a project that aims to personalized 3D brain images to help neurosurgeons. This project aims to use MRI data known as Resting-State Functional MRI (rsfMRI). This technique helps surgeons to detect typical functioning areas of brain with 3D images of brain’s anatomy. Thus, this project helps surgeons to remove brain tumor with minimal risk.

 Request a free sample copy or view report summary: Brain Mapping Instruments Market Report

Brain Mapping Instruments Market Report Highlights

• Computed Axial Tomography (CAT) dominated the market segment in 2023 with the highest market share owing its assistance to doctors by providing them accurate 3D images of the internal organs and structures of the body such as, small nodules or tumors which cannot be seen by a normal X-ray.

• Electroencephalography (EEG) is expected to experience the fastest growth over the forecast period.

• North America dominated the brain mapping instruments market with the highest revenue share in 2023 owing to the technological advancements, awareness of brain mapping instruments and rising health concerns in the region.

Brain Mapping Instruments Market Segmentation

Grand View Research has segmented the brain mapping instruments market report based on product and region.

Brain Mapping Instruments Product Outlook (Revenue, USD Million, 2018 - 2030)

• Computed Axial Tomography (CAT)

• Positron Emission Tomography (PET)

• Electroencephalography (EEG)

• Magnetoencephalography

• Functional MRI (fMRI)

• Functional Near-Infrared Spectroscopy (fNIRS)

• Others

Brain Mapping Instruments Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America

  • U.S.

  • Canada

  • Mexico

• Europe

  • Germany

  • UK

  • France

  • Italy

  • Spain

  • Denmark

  • Sweden

  • Norway

• Asia Pacific

  • China

  • Japan

  • India

  • South Korea

  • Australia

  • Thailand

• Latin America

  • Brazil

  • Argentina

• Middle East and Africa (MEA)

  • Saudi Arabia

  • UAE

  • South Africa

  • Kuwait

List of Key Players of Brain Mapping Instruments Market

• Medtronic

• GE HealthCare

• Koninklijke Philips N.V.

• Siemens Healthcare Private Limited

• Advanced Brain Monitoring, Inc.

• natus

• BrainScope Company Inc

• Brain Products GmbH

• Compumedics Limited

• NIHON KOHDEN CORPORATION